Transforming India’s approach to cancer care
In India, a country with a vast population and a diverse socio-economic fabric, healthcare remains fraught with challenges including disparities in access. These socio-economic disparities are deep, and
In India, a country with a vast population and a diverse socio-economic fabric, healthcare remains fraught with challenges including disparities in access. These socio-economic disparities are deep, and
The government today asserted India would invoke the flexibility it had under the WTO agreement on Trade Related Intellectual Property Rights (TRIPs) for compulsory licensing of patented drugs to ensure
In a landmark move, the Indian Patent Office announced on Monday that it has issued its first compulsory license to a domestic generic drug-maker. The decision effectively ends German pharmaceutical company
Cancer-treatment drug Nexavar will soon be available at Rs. 8,880 per pack of 120 tablets. Bayer, a German multi-national, holds the patent for Nexavar (the brand name of sorafenib tosylate), which now sells at Rs.2.84 lakh. The way for such a huge reduction in the price is cleared with India invoking a World Trade Organisation (WTO) provision and permitting the Hyderabad-based Natco Pharma to make sorafenib tosylate, which is used to treat kidney and liver cancer.
India’s first compulsory licence worries MNC drugmakers The government has allowed a local drugmaker to make and sell a patented cancer drug at a fraction of the price charged by Germany’s Bayer AG, setting
The government proposes to convert the National Rural Health Mission (NRHM) into a National Health Mission to provide health care to the urban poor also, in the course of the 12th Plan. Universal access to free generic essential medicines in public health institutions in a phased and time-bound manner will be ensured. Announcing major initiatives to provide universal healthcare, President Pratibha Patil on Monday said the government would endeavour to increase both Plan and Non-Plan public expenditure in the Centre and the States
Mumbai: In a landmark decision that could set a precedent on how life-saving drugs under patents can be made affordable, the government has allowed a domestic company, Natco Pharma, to manufacture a copycat
Coca-Cola Co. and PepsiCo Inc. are changing the way they make the caramel coloring used in their sodas as a result of a California law that mandates drinks containing a certain level of carcinogens bear
Bathinda: A nuclear physicist, Hardev Singh Vir, would be conducting an independent study on the source of uranium and to ascertain whether it is to blame for the high incidence of cancer cases in the
JAIPUR: Information and public relations minister Jitendra Singh on Sunday said the state government will make all efforts to make cancer treatment 100% free in the state which include various therapies related to cancer treatment. He was speaking at a free camp to cousel cancer patients organised by the Rajasthan Cancer Detection and Welfare Society and NROI Rajasthan Chapter at Jaipur Medical Association's building in Sawai Man Singh (SMS) hospital.
Implications well beyond cola market; demands for similar enforcement here of new US standard Coca-Cola India will import caramel made through a modified process from its international suppliers to allay any fear that excessive drinking of colas could have an adverse impact on health. However, no deadline for the change has been fixed by the soft drinks major.